The company's production complex Orisil-Pharm systematically undergoes inspection by the State Service for Medicines. As a result of the last inspection, we received a Certificate of Compliance with the Production Conditions Requirements GMP.

This is another huge victory that the entire company team is proud of. Orisil-Pharm, because we have been going to this for 10 years. This is a long path of hard work, self-development, as well as significant investments in production facilities, their improvement and modernization. We never stop at what we have achieved. After all, such events give even more strength and inspiration to work and develop for the benefit of society.

Brief description of the international standard GMP.
Standard Good Manufacturing Practice (trans. from English – good manufacturing practice) – a set of rules and regulations that describe the requirements for production activities and quality control of medicines, biologically active supplements, food products, medical devices, and diagnostic products.

Standard GMP intended for:

• ensuring an excellent level of quality and reliability of manufactured products
• guarantees that the drug is made according to the same formula as declared for production
• does not contain third-party applications
• labeled and packaged as required
• does not lose its properties during the shelf life.

This international standard sets requirements for the quality management system, personnel management, requirements for the equipment used and production buildings, as well as requirements for document management. Everything must meet the highest quality requirements.

The #RightToChoice campaign is our public call for honesty and transparency in the pharmaceutical market, aimed at protecting the rights and health of patients.

Today in Ukraine, major players in the pharmaceutical market increasingly influence which drugs patients receive. Consumers are increasingly finding themselves in a situation where pharmacies do not give them a choice, but impose “the same”, “no worse”, “similar”. But in reality, it is not always the same. The difference may be in the quality of raw materials, levels of purification, bioavailability, production control, effectiveness in critical conditions. These are not just nuances, but the principles on which evidence-based medicine is based, which affect the health of patients. Therefore, we decided to raise this topic publicly and start a public discussion.

The # Right to Choose video exposes a dangerous system of drug substitution and monopolization. It aims to convey to the public that it is not permissible to substitute a doctor's prescription or impose one's own trademarks (VTM) on the consumer under the guise of «of the same". We advocate for the choice of drug to be transparent and based on the informed consent of the patient, not on marketing strategies or commercial agreements of networks.

This is not about a conflict with the industry, but about protecting a fundamental principle: the consumer's right to informed choice. We respect the work of pharmacists and understand the pressure they work under. It is about ethical boundaries: you cannot substitute a doctor's decision or a patient's expectations for your own commercial goals. And the lack of clear regulation of the imposition of TMs leads to the systematic practice of such substitution.

The message of #RightToChoose is clear and it is:

• About the patient's right to choose. The patient should know what they are buying. A substitute is not always “the same,” and “cheaper” is not always safer.
• About proven quality. Atoxil is a drug with a long history of clinical efficacy, certified production and full quality control. We do not compete with copies, we advocate responsible treatment, when the result for the patient is the main thing.
• About professional honor. We want pharmacists to be able to recommend to their clients, without any pressure, exactly those drugs that they themselves, as professionals, are convinced of their effectiveness and safety. So that they can sell without obstacles what really helps, and not what is a point of the company's financial strategy.
• On the inadmissibility of market monopolization, which undermines trust in the entire pharmaceutical industry.Abuse of control over the sale of drugs is a way to lose the reputation of Ukrainian pharmacy, which has been built up over decades. When consumers systematically receive dubious “analogues” instead of high-quality, proven drugs, they will sooner or later begin to doubt the integrity of all market players.

We advocate for transparency, honesty and ethics in the pharmaceutical sector.
Pharmacy should work according to the principles of evidence-based medicine, not commercial priorities. Health is not a space for experiments. This is the responsibility of each of us: a doctor, a pharmacist, a manufacturer, a pharmacy chain.

We do not question the right of pharmacy chains to develop their business, create their own brands and make a profit. But these rights should not diminish the rights of others: the patient's right to know the truth, the doctor's right to authoritative prescription, the manufacturer's right to be represented honestly. We stand for freedom of choice, for freedom of competition, for the protection of consumer rights - and we consider it our duty as honest people, – note at Orisil-Pharm.

This year, Medical Worker's Day, June 21, is not only a significant holiday in the professional community, but also an important day for each of us to once again thank those doctors who were on the front lines for their dedication, incredible humanity, and help to patients, despite all the barriers and difficulties, during the pandemic. COVID-19. 

That is why, the other day, we donated our own hand disinfectants, Orisept, to Kalush medical institutions. After each manipulation, each contact, medical workers treat their hands with an antiseptic. Therefore, it is very important to us that this is a high-quality product that is safe for health. 

 "For several months now, "In today's difficult conditions, doctors in Ukraine show aerobatics in their work and daily confirm their dedication to the profession with their actions," he notes. Maksym Kishchak and emphasizes that «lDoctors of various specialties, nurses, laboratory assistants and paramedics, pharmacists, and druggists are now not only conscientiously performing their work, and also They ensure stability in the country. And we all, as a community, should support them in any way we can. Each of us, young or old, in the village or in the city, has something to thank doctors for.

The initiative of Orisil-Pharm was also noted Natalia Tabachuk, Deputy Mayor of Kalush for Medical Affairs, and Natalia Kinash, medical director for inpatient work Kaluga Central District Hospital and Mykhailo Hawrylyshyn, Director of the Kaluga City Center for Primary Medical and Sanitary Assistance.

We are pleased to inform you that from now on, the list of products of the Orisil-Pharm company is supplemented by the antiseptic agent “Orisept”.

"Orisil-Pharm" congratulates its colleagues and partners on the New Year

Company "Orisil-Pharm" On behalf of the director and founder of Kishchak Maksym Mykolayovych, he expresses his official position on this issue:
"For more than 15 years, we have been producing sorbents based on silicon dioxide, our portfolio includes both medicines and dietary supplements, which are produced in compliance with the highest quality standards. We can say that the creation of preparations based on silicon dioxide is our key competence. That is why we believe that the norms proposed by the Ministry of Health do not correspond to European practice and require appropriate revision. I also want to note that the company "Orisil-Pharm" always adheres to the principle of fair competition and transparent rules of the game. We do not support lobbying actions that can harm society."

Who benefits from the shortage of sorbents and why? APTEKA.UA

Orisil-Pharm strives to provide patients with high-quality and innovative drugs that are as comfortable and convenient to use as possible. That is why we have developed and introduced a new packaging design for Atoxil gel, convenient for patients and pharmacists, which has maximum visual impact, conveys key information and is quickly identifiable.
Atoxil gel in new packaging has already appeared in pharmacies in Ukraine.

The incredible experience, knowledge, and level of quality that we have today is a huge credit to a close-knit professional team and a clearly organized management system.
Our company is, first and foremost, people who have been working together towards the same goal all these years and believe in a better future for the company!
Over the 15 years of Orisil-pharm's activity, many achievements have been accumulated, but we are not going to stop there and will continue to move forward along an innovative path of development and with promising views on the future!
The official celebration took place on November 2 in an atmosphere of joyful smiles and sincere communication, the company's employees had the opportunity to get to know each other better and share holiday impressions.
The celebration of the company's 15th anniversary further united the friendly team, gave incredible emotions and a desire to reach even greater heights for the benefit of the company.

Company Orisil-Pharm received another international quality certificate ISO 13485. This certificate is a recognized standard in the medical field and allows the supply of certified products to all countries of the world.
This is another achievement of the company on the path of improvement and impeccable quality of products with the thought of our consumers in Ukraine and abroad.